• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中的心脏磁共振成像:诊断与预后评估

Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.

作者信息

Pezzini Sara, Daus Francesca, Galli Giorgia, Farina Andrea, Fragasso Gabriele, Spoladore Roberto

机构信息

Health Science Department, University of Milan-Bicocca, 20126 Milan, Italy.

Cardiovascular Imaging Unit, Division of Cardiology, Alessandro Manzoni Hospital, 23900 Lecco, Italy.

出版信息

J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.

DOI:10.3390/jcdd12060200
PMID:40558635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193542/
Abstract

With its high spatial resolution and tissue contrast, cardiac magnetic resonance (CMR) is an extremely flexible imaging technique that enables a thorough morphological and functional evaluation of the heart and vascular system. From diagnosis to treatment planning and risk assessment, CMR is being utilized more and more in the evaluation of patients with heart failure (HF). CMR offers a variety of techniques for characterizing myocardial tissue, aiding in identifying the cause of HF, as well as whole-heart cine imaging for precise measurement of biventricular dimensions and function. The aim of this review is to the describe the role of CMR in chronic heart failure, in particular for diagnostic workups, differential diagnosis, and information on how CMR influences treatment planning choices.

摘要

凭借其高空间分辨率和组织对比度,心脏磁共振成像(CMR)是一种极其灵活的成像技术,能够对心脏和血管系统进行全面的形态学和功能评估。从诊断到治疗规划和风险评估,CMR在心力衰竭(HF)患者的评估中越来越多地得到应用。CMR提供了多种用于心肌组织特征化的技术,有助于确定HF的病因,以及用于精确测量双心室尺寸和功能的全心电影成像。本综述的目的是描述CMR在慢性心力衰竭中的作用,特别是在诊断检查、鉴别诊断以及CMR如何影响治疗规划选择方面的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/de4d64a06239/jcdd-12-00200-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/441337007227/jcdd-12-00200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/b2dfba9fef3e/jcdd-12-00200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/a3795b70a8c0/jcdd-12-00200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/cc8214d26b02/jcdd-12-00200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/1b9b74d90fea/jcdd-12-00200-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/6c24ea7e4e82/jcdd-12-00200-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/92101a8c6ac3/jcdd-12-00200-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/de4d64a06239/jcdd-12-00200-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/441337007227/jcdd-12-00200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/b2dfba9fef3e/jcdd-12-00200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/a3795b70a8c0/jcdd-12-00200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/cc8214d26b02/jcdd-12-00200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/1b9b74d90fea/jcdd-12-00200-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/6c24ea7e4e82/jcdd-12-00200-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/92101a8c6ac3/jcdd-12-00200-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb7/12193542/de4d64a06239/jcdd-12-00200-g008.jpg

相似文献

1
Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments.心力衰竭中的心脏磁共振成像:诊断与预后评估
J Cardiovasc Dev Dis. 2025 May 23;12(6):200. doi: 10.3390/jcdd12060200.
2
Rationale and design of the HERZCHECK trial: Detection of early heart failure using telemedicine and cardiovascular magnetic resonance in structurally weak regions (NCT05122793).HERZCHECK试验的原理与设计:在结构薄弱地区使用远程医疗和心血管磁共振检测早期心力衰竭(NCT05122793)
J Cardiovasc Magn Reson. 2025 Jan 15;27(1):101841. doi: 10.1016/j.jocmr.2025.101841.
3
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
4
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.终末期心力衰竭患者使用左心室辅助装置的临床疗效及成本效益:一项系统评价与经济学评估
Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. doi: 10.3310/hta9450.
5
Validating real-time three-dimensional echocardiography against cardiac magnetic resonance, for the determination of ventricular mass, volume and ejection fraction: a meta-analysis.实时三维超声心动图与心脏磁共振对比评估心室质量、容积和射血分数的验证:荟萃分析。
Clin Res Cardiol. 2024 Mar;113(3):367-392. doi: 10.1007/s00392-023-02204-5. Epub 2023 Apr 20.
6
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy - a systematic review of the literature.心脏磁共振成像在识别心脏再同步治疗合适候选者中的作用——文献系统综述
Heart Fail Rev. 2022 Nov;27(6):2095-2118. doi: 10.1007/s10741-022-10263-5. Epub 2022 Aug 31.
7
Enhancing Preoperative Diagnosis of Subscapular Muscle Injuries with Shoulder MRI-based Multimodal Radiomics.基于肩部MRI的多模态放射组学增强肩胛下肌损伤的术前诊断
Acad Radiol. 2025 Feb;32(2):907-915. doi: 10.1016/j.acra.2024.09.049. Epub 2024 Oct 5.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Cardiac MRI-derived mean right atrial pressure and its prognostic importance.心脏磁共振成像得出的平均右心房压力及其预后重要性。
Open Heart. 2025 Jun 22;12(1):e003216. doi: 10.1136/openhrt-2025-003216.
10
CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials.CMR 成像评估冠心病导致慢性心室功能障碍患者的存活能力:前瞻性试验的荟萃分析。
JACC Cardiovasc Imaging. 2012 May;5(5):494-508. doi: 10.1016/j.jcmg.2012.02.009.

引用本文的文献

1
Longitudinal Myocardial Deformation as an Emerging Biomarker for Post-Traumatic Cardiac Dysfunction.纵向心肌变形作为创伤后心脏功能障碍的一种新兴生物标志物。
Life (Basel). 2025 Jun 30;15(7):1052. doi: 10.3390/life15071052.

本文引用的文献

1
Cardiac diagnoses and long-term outcomes in ring-like late gadolinium enhancement evaluated by cardiac magnetic resonance.通过心脏磁共振评估的环状晚期钆增强的心脏诊断及长期预后
Eur Heart J Cardiovasc Imaging. 2025 Apr 30;26(5):841-852. doi: 10.1093/ehjci/jeaf055.
2
Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-Analysis.MRI-ECV 监测 Tafamidis 在ATTR 心脏淀粉样变性中的疗效:系统评价和荟萃分析。
Tomography. 2024 Aug 16;10(8):1303-1311. doi: 10.3390/tomography10080097.
3
The Role of Magnetic Resonance Imaging in Risk Stratification of Patients with Acute Myocarditis.
磁共振成像在急性心肌炎患者风险分层中的作用
Diagnostics (Basel). 2024 Jul 3;14(13):1426. doi: 10.3390/diagnostics14131426.
4
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies.磁共振成像特征及扩张型和心律失常性左心室心肌病的临床转归。
J Am Coll Cardiol. 2024 May 14;83(19):1841-1851. doi: 10.1016/j.jacc.2024.02.041.
5
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2024 AHA/ACC/AMSSM/HRS/PACES/SCMR 肥厚型心肌病管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2024 Jun 4;149(23):e1239-e1311. doi: 10.1161/CIR.0000000000001250. Epub 2024 May 8.
6
Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.心脏磁共振成像组织图谱对心脏淀粉样变性预后的评估:一项系统综述和荟萃分析
Int J Cardiol. 2024 May 15;403:131892. doi: 10.1016/j.ijcard.2024.131892. Epub 2024 Feb 19.
7
Atrial and Ventricular Strain Imaging Using CMR in the Prediction of Ventricular Arrhythmia in Patients with Myocarditis.使用心脏磁共振成像进行心房和心室应变成像在预测心肌炎患者室性心律失常中的应用
J Clin Med. 2024 Jan 23;13(3):662. doi: 10.3390/jcm13030662.
8
Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis.晚期钆增强与扩张型心肌病预后的关联:一项荟萃分析。
World J Radiol. 2023 Nov 28;15(11):324-337. doi: 10.4329/wjr.v15.i11.324.
9
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
10
Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation.非缺血性扩张型心肌病晚期钆增强分布模式:基因型-表型相关性。
Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):75-85. doi: 10.1093/ehjci/jead184.